Oncology & Cancer
Study identifies genetic risk factors for leukemia
Researchers have discovered that there is a genetic susceptibility to developing acute myeloid leukemia, a cancer of the white blood cells.
Nov 1, 2021
0
73
News tagged with myeloid leukaemia
Oncology & Cancer
After 40 years in limbo: Styrene is probably carcinogenic
For 40 years, researchers have believed there is an increased risk of cancer associated with styrene. Now, a working group under the auspices of the WHO and appointed by the International Agency for Research on Cancer (IARC), ...
Jun 1, 2018
0
30
Oncology & Cancer
Unforeseen new drug target discovered for acute myeloid leukemia
A study has found an unexpected new drug target for acute myeloid leukaemia (AML) that could open new avenues to develop effective treatments against this potentially lethal disease. Researchers from the Wellcome Trust Sanger ...
Nov 27, 2017
0
34
Oncology & Cancer
Non-invasive imaging could help match leukaemia patients with treatments
Researchers at the Francis Crick Institute have identified visual changes in the bone marrow caused by acute myeloid leukemia (AML). The imaging technique used is now being tested in hospital to see if it could help predict ...
Aug 3, 2021
0
125
Medical research
RNA interference for human therapy
Leading scientists in the field investigated the potential of RNA interference (RNAi) technology as a therapeutic intervention for down-regulating the expression of disease-associated genes. Project deliverables hold significant ...
Sep 20, 2012
0
0
Oncology & Cancer
Researchers identify new protein linked to leukaemia growth
(Medical Xpress)—Their work has identified a protein called PIP4K2A that could be a new target in drug development.
May 16, 2014
0
0
Oncology & Cancer
First demonstration of anti-cancer activity for an IDH1 mutation inhibitor
A phase I trial of the first drug designed to inhibit the cancer-causing activity of a mutated enzyme known as isocitrate dehydrogenase (IDH) 1, which is involved in cell metabolism, has shown clinical activity in patients ...
Nov 18, 2014
0
0
Oncology & Cancer
Finding and targeting a tumor's sweet spot to eradicate aggressive form of leukemia
A highly aggressive common form of leukemia which is activated by mutations in signaling molecules is maintained by a web of regulatory proteins downstream of these signals.
Dec 20, 2023
0
21
Oncology & Cancer
Combination of ground-breaking treatments offer powerful new path for blood cancer therapies
Researchers at Monash University and Peter MacCallum Cancer Centre have identified for the first time how a new class of epigenetic drug engages with the immune system to kill off cancer cells, offering powerful new pathways ...
Mar 1, 2017
0
1
Oncology & Cancer
Stealing from the body—how cancer recharges its batteries
New research published today uncovers how the blood cancer 'steals' parts of surrounding healthy bone marrow cells to thrive, in work that could help form new approaches to cancer treatment in the future.
Oct 5, 2017
0
0
